Skip to Main Content

It’s the biotechnology industry’s turn to dazzle Donald Trump — or at least to try — in a meeting at the White House on Monday. Top on the agenda: the hot debate over federal funding for biomedical research.

Given the players — and the politics — fireworks could ensue. Here, five things we’ll be watching:

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED